ArticleInternal medicine (Tokyo, Japan)2018

Improvement of Proteinuria due to Combination Therapy with Daclatasvir and Asunaprevir in Hepatitis C Virus-associated Renal Disease without Cryoglobulinemia.

Satoshi Takakusagi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.